218 related articles for article (PubMed ID: 35483239)
1. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD.
Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Kaneko K; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
J Neurol Sci; 2022 Jun; 437():120269. PubMed ID: 35483239
[TBL] [Abstract][Full Text] [Related]
2. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients.
Pache F; Zimmermann H; Mikolajczak J; Schumacher S; Lacheta A; Oertel FC; Bellmann-Strobl J; Jarius S; Wildemann B; Reindl M; Waldman A; Soelberg K; Asgari N; Ringelstein M; Aktas O; Gross N; Buttmann M; Ach T; Ruprecht K; Paul F; Brandt AU;
J Neuroinflammation; 2016 Nov; 13(1):282. PubMed ID: 27802824
[TBL] [Abstract][Full Text] [Related]
3. Differentiating Multiple Sclerosis From AQP4-Neuromyelitis Optica Spectrum Disorder and MOG-Antibody Disease With Imaging.
Cortese R; Prados Carrasco F; Tur C; Bianchi A; Brownlee W; De Angelis F; De La Paz I; Grussu F; Haider L; Jacob A; Kanber B; Magnollay L; Nicholas RS; Trip A; Yiannakas M; Toosy AT; Hacohen Y; Barkhof F; Ciccarelli O
Neurology; 2023 Jan; 100(3):e308-e323. PubMed ID: 36192175
[TBL] [Abstract][Full Text] [Related]
4. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis.
Molazadeh N; Akaishi T; Bose G; Nishiyama S; Chitnis T; Levy M
Mult Scler Relat Disord; 2023 Dec; 80():105093. PubMed ID: 37949025
[TBL] [Abstract][Full Text] [Related]
5. Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations.
Remlinger J; Bagnoud M; Meli I; Massy M; Hoepner R; Linington C; Chan A; Bennett JL; Enzmann V; Salmen A
Neurol Neuroimmunol Neuroinflamm; 2023 Sep; 10(5):. PubMed ID: 37429715
[TBL] [Abstract][Full Text] [Related]
6. Leptomeningeal Enhancement in Pediatric Anti-Myelin Oligodendrocyte Glycoprotein Antibody Disease, Multiple Sclerosis, and Neuromyelitis Optica Spectrum Disorder.
Goldman-Yassen A; Lee A; Gombolay G
Pediatr Neurol; 2024 Apr; 153():125-130. PubMed ID: 38382244
[TBL] [Abstract][Full Text] [Related]
7. Retinal structural and microvascular deterioration independent of optic neuritis in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders: An optical coherence tomography angiography study.
Wang M; Wang W; Liu S; Ma J; Wang X; Chou Y; Gan L; Zhang X; Shao E; Zhong Y; Xu Y
Mult Scler Relat Disord; 2024 Apr; 84():105423. PubMed ID: 38359691
[TBL] [Abstract][Full Text] [Related]
8. Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS.
Redenbaugh V; Chia NH; Cacciaguerra L; McCombe JA; Tillema JM; Chen JJ; Lopez Chiriboga AS; Sechi E; Hacohen Y; Pittock SJ; Flanagan EP
Mult Scler; 2023 Jun; 29(7):799-808. PubMed ID: 37218499
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome measures in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).
Gericke FC; Hanson JVM; Hackenberg A; Gerth-Kahlert C
Eur J Paediatr Neurol; 2024 Jan; 48():113-120. PubMed ID: 38217965
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders.
Ringelstein M; Ayzenberg I; Lindenblatt G; Fischer K; Gahlen A; Novi G; Hayward-Könnecke H; Schippling S; Rommer PS; Kornek B; Zrzavy T; Biotti D; Ciron J; Audoin B; Berthele A; Giglhuber K; Zephir H; Kümpfel T; Berger R; Röther J; Häußler V; Stellmann JP; Whittam D; Jacob A; Kraemer M; Gueguen A; Deschamps R; Bayas A; Hümmert MW; Trebst C; Haarmann A; Jarius S; Wildemann B; Grothe M; Siebert N; Ruprecht K; Paul F; Collongues N; Marignier R; Levy M; Karenfort M; Deppe M; Albrecht P; Hellwig K; Gold R; Hartung HP; Meuth SG; Kleiter I; Aktas O;
Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34785575
[TBL] [Abstract][Full Text] [Related]
11. Radiologic Lag and Brain MRI Lesion Dynamics During Attacks in MOG Antibody-Associated Disease.
Cacciaguerra L; Abdel-Mannan O; Champsas D; Mankad K; Krecke KN; Chen JJ; Syc-Mazurek SB; Redenbaugh V; Lopez-Chiriboga AS; Valencia-Sanchez C; Hemingway C; Tillema JM; Ciccarelli O; Pittock SJ; Hacohen Y; Flanagan EP
Neurology; 2024 May; 102(10):e209303. PubMed ID: 38710000
[TBL] [Abstract][Full Text] [Related]
12. Grey Matter Atrophy and its Relationship with White Matter Lesions in Patients with Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease, Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder, and Multiple Sclerosis.
Cortese R; Battaglini M; Prados F; Gentile G; Luchetti L; Bianchi A; Haider L; Jacob A; Palace J; Messina S; Paul F; Marignier R; Durand-Dubief F; de Medeiros Rimkus C; Apostolos Pereira SL; Sato DK; Filippi M; Rocca MA; Cacciaguerra L; Rovira À; Sastre-Garriga J; Arrambide G; Liu Y; Duan Y; Gasperini C; Tortorella C; Ruggieri S; Amato MP; Ulivelli M; Groppa S; Grothe M; Llufriu S; Sepulveda M; Lukas C; Bellenberg B; Schneider R; Sowa P; Celius EG; Pröbstel AK; Granziera C; Yaldizli Ö; Müller J; Stankoff B; Bodini B; Barkhof F; Ciccarelli O; De Stefano N;
Ann Neurol; 2024 May; ():. PubMed ID: 38780377
[TBL] [Abstract][Full Text] [Related]
13. Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders.
Cacciaguerra L; Flanagan EP
Neurol Clin; 2024 Feb; 42(1):77-114. PubMed ID: 37980124
[TBL] [Abstract][Full Text] [Related]
14. Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD.
Duchow A; Bellmann-Strobl J; Friede T; Aktas O; Angstwurm K; Ayzenberg I; Berthele A; Dawin E; Engels D; Fischer K; Flaskamp M; Giglhuber K; Grothe M; Havla J; Hümmert MW; Jarius S; Kaste M; Kern P; Kleiter I; Klotz L; Korporal-Kuhnke M; Kraemer M; Krumbholz M; Kümpfel T; Lohmann L; Ringelstein M; Rommer P; Schindler P; Schubert C; Schwake C; Senel M; Then Bergh F; Tkachenko D; Tumani H; Trebst C; Vardakas I; Walter A; Warnke C; Weber MS; Wickel J; Wildemann B; Winkelmann A; Paul F; Stellmann JP; Häußler V;
Ann Neurol; 2024 Apr; 95(4):720-732. PubMed ID: 38086777
[TBL] [Abstract][Full Text] [Related]
15. Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS.
Webb LM; Cacciaguerra L; Krecke KN; Chen JJ; Sechi E; Redenbaugh V; Dubey D; Pittock SJ; Flanagan EP
J Neurol Sci; 2023 Jul; 450():120687. PubMed ID: 37201267
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD.
Redenbaugh V; Flanagan EP
Neurotherapeutics; 2022 Apr; 19(3):808-822. PubMed ID: 35267170
[TBL] [Abstract][Full Text] [Related]
17. Serum Proteomics Distinguish Subtypes of NMO Spectrum Disorder and MOG Antibody-Associated Disease and Highlight Effects of B-Cell Depletion.
Gawde S; Siebert N; Ruprecht K; Kumar G; Ko RM; Massey K; Guthridge JM; Mao-Draayer Y; Schindler P; Hastermann M; Pardo G; Paul F; Axtell RC
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200268. PubMed ID: 38885457
[TBL] [Abstract][Full Text] [Related]
18. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
Carnero Contentti E; Okuda DT; Rojas JI; Chien C; Paul F; Alonso R
J Neuroimaging; 2023; 33(5):688-702. PubMed ID: 37322542
[TBL] [Abstract][Full Text] [Related]
19. Astrocytic outer retinal layer thinning is not a feature in AQP4-IgG seropositive neuromyelitis optica spectrum disorders.
Lu A; Zimmermann HG; Specovius S; Motamedi S; Chien C; Bereuter C; Lana-Peixoto MA; Fontenelle MA; Ashtari F; Kafieh R; Dehghani A; Pourazizi M; Pandit L; D'Cunha A; Kim HJ; Hyun JW; Jung SK; Leocani L; Pisa M; Radaelli M; Siritho S; May EF; Tongco C; De Sèze J; Senger T; Palace J; Roca-Fernández A; Leite MI; Sharma SM; Stiebel-Kalish H; Asgari N; Soelberg KK; Martinez-Lapiscina EH; Havla J; Mao-Draayer Y; Rimler Z; Reid A; Marignier R; Cobo-Calvo A; Altintas A; Tanriverdi U; Yildirim R; Aktas O; Ringelstein M; Albrecht P; Tavares IM; Bichuetti DB; Jacob A; Huda S; Soto de Castillo I; Petzold A; Green AJ; Yeaman MR; Smith TJ; Cook L; Paul F; Brandt AU; Oertel FC;
J Neurol Neurosurg Psychiatry; 2022 Feb; 93(2):188-195. PubMed ID: 34711650
[TBL] [Abstract][Full Text] [Related]
20. Higher longitudinal brain white matter atrophy rate in aquaporin-4 IgG-positive NMOSD compared with healthy controls.
Masuda H; Mori M; Hirano S; Uzawa A; Uchida T; Muto M; Ohtani R; Aoki R; Hirano Y; ; Kuwabara S
Sci Rep; 2023 Aug; 13(1):12631. PubMed ID: 37537208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
